Plain-English translation of NCT07546695 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This is a research study that examines medical records from patients with HER2-positive or triple-negative breast cancer who received chemotherapy before surgery. Researchers want to understand whether it is safe to skip removing all the lymph nodes under the arm in patients who still have cancer in some lymph nodes after chemotherapy, or whether additional lymph node removal or radiation is necessary.
Current treatment guidelines are unclear about the best approach for patients whose lymph nodes still contain cancer after chemotherapy. By studying what happened to patients who had different treatments, researchers hope to give clearer guidance to doctors and patients about which approach—removing all lymph nodes, giving radiation, or doing nothing extra—is safest and works best.
You likely qualify if…
You likely don't qualify if…
This is a retrospective study, which means researchers will review your existing medical records—they will not ask you to have new appointments, treatments, or tests. If you are eligible and agree to participate, your doctors will allow the research team to access and analyze your surgical and pathology records to understand your treatment and long-term outcomes. There are no active study visits or procedures required.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Switzerland